標題: Titlebook: Global Pharmaceutical Policy; Zaheer-Ud-Din Babar Book 2020 The Editor(s) (if applicable) and The Author(s) 2020 Pharmaceutical policy.cou [打印本頁] 作者: dilate 時間: 2025-3-21 19:31
書目名稱Global Pharmaceutical Policy影響因子(影響力)
書目名稱Global Pharmaceutical Policy影響因子(影響力)學科排名
書目名稱Global Pharmaceutical Policy網絡公開度
書目名稱Global Pharmaceutical Policy網絡公開度學科排名
書目名稱Global Pharmaceutical Policy被引頻次
書目名稱Global Pharmaceutical Policy被引頻次學科排名
書目名稱Global Pharmaceutical Policy年度引用
書目名稱Global Pharmaceutical Policy年度引用學科排名
書目名稱Global Pharmaceutical Policy讀者反饋
書目名稱Global Pharmaceutical Policy讀者反饋學科排名
作者: 失眠癥 時間: 2025-3-21 20:59
Md Nazrul Islam,Md Saidul Islam competitive-bidding system and so on. The Center of Drug Safety and Policy (CDSP), situated in Xi’an Jiaotong University (XJTU) and founded in 2014, is working on pharmaceutical policy issues and providing the necessary evidence showing the efficiency of these policies. The results of these studies are reported in this chapter.作者: 氣候 時間: 2025-3-22 03:40 作者: 隱語 時間: 2025-3-22 05:09 作者: Metastasis 時間: 2025-3-22 09:12 作者: languid 時間: 2025-3-22 14:07
Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to to us as researchers and practitioners in the pharmaceutical policy and pharmacy practice space. It is good practice as researchers to look backwards as well as forwards! Has much changed, are these issues still there or have some of them been addressed and are resolved?作者: languid 時間: 2025-3-22 20:17 作者: 姑姑在炫耀 時間: 2025-3-22 22:05
Argumentative Hakims: Debates in the ,ggered. A threshold is an estimate of the maximum use of any antibiotic in a population that can be used over a specific period without having resistance to that antibiotic. A policy of use aimed at not exceeding those thresholds for each antibiotic can be established, hoping that problematic resistance would remain at acceptable levels.作者: 行乞 時間: 2025-3-23 05:25
Book 2020l pharmaceutical policy is ever-evolving and data and quality ‘research-based information’ in this field are scarce. This book fills this gap and provides up-to-date empirical information and evidence-based synthesis. It focuses on pertinent key issues in global pharmaceutical policy including medic作者: occurrence 時間: 2025-3-23 08:22 作者: recede 時間: 2025-3-23 13:20 作者: Allergic 時間: 2025-3-23 14:20
https://doi.org/10.1007/978-4-431-67899-1ies. It also synthesizes key literature and, at the end of this chapter, there is a case study on Pakistan’s pharmacovigilance set-up. The chapter also includes suggestions for the future research agenda to improve medicines safety globally.作者: 商業(yè)上 時間: 2025-3-23 20:21 作者: profligate 時間: 2025-3-23 22:40
https://doi.org/10.1007/978-3-031-49963-0ements, with a particular focus on their limitations. New models to address these drawbacks are presented; these include methodological support tools, collaborative approaches and improved transparency.作者: 智力高 時間: 2025-3-24 04:14 作者: 高歌 時間: 2025-3-24 10:02
Lothar H?berle,Johannes Hattlerprocurement prices in Russia (2010–2017) and documented success of government interventions in reduction of essential and cardiovascular patient prices from 2010 onwards to recommended values for generics in public sector and the need for continued price monitoring.作者: placebo 時間: 2025-3-24 11:37
https://doi.org/10.1057/9781137466082gulatory agencies and in health technology assessment. We finalize by providing specific examples of public participation, using case studies from HIV, cancer and rare diseases, all of which support the essential role of citizens in modelling access to medication.作者: APEX 時間: 2025-3-24 18:55 作者: insecticide 時間: 2025-3-24 21:12
Medicines Safety in the Globalized Context,ies. It also synthesizes key literature and, at the end of this chapter, there is a case study on Pakistan’s pharmacovigilance set-up. The chapter also includes suggestions for the future research agenda to improve medicines safety globally.作者: 外表讀作 時間: 2025-3-25 02:00 作者: 抗原 時間: 2025-3-25 04:43
Medicines Pricing: Limitations of Existing Policies and New Models,ements, with a particular focus on their limitations. New models to address these drawbacks are presented; these include methodological support tools, collaborative approaches and improved transparency.作者: Antecedent 時間: 2025-3-25 08:51 作者: 六邊形 時間: 2025-3-25 15:41 作者: 淘氣 時間: 2025-3-25 16:06 作者: HERTZ 時間: 2025-3-25 20:15 作者: 夾克怕包裹 時間: 2025-3-26 01:18
Global Access to Cancer Medicines,s to part of the listed anticancer drugs at high copayment or full cost, and access to these medicines is limited due to poorly available supply problems. Moreover, recently approved medicines targeting metastatic cancers are often unavailable or available only when patients are charged more. This l作者: 注意到 時間: 2025-3-26 05:26 作者: mucous-membrane 時間: 2025-3-26 09:42
Access and Use of Medicines in Ukraine,e extent of healthcare services and medicines that will be completely covered by the state. The state budget assigned to health is around 5% of gross domestic product. The National Health Service of Ukraine was established as a single national health-care purchaser. A new essential medicines list de作者: Carcinoma 時間: 2025-3-26 14:52
Diagnostic Criteria for Giant Cell Arteritiss to part of the listed anticancer drugs at high copayment or full cost, and access to these medicines is limited due to poorly available supply problems. Moreover, recently approved medicines targeting metastatic cancers are often unavailable or available only when patients are charged more. This l作者: Thyroid-Gland 時間: 2025-3-26 18:11
Post-discharge Complications of Stroke, and irrational practices, pharmacovigilance (PV) and adverse drug reaction reporting, community pharmacy practices, emerging role of pharmacists, access to medicines, the concept of generic medicines and practice-based research..It is interesting to see the umbrella of pharmacy practice and policy 作者: 極微小 時間: 2025-3-27 00:40 作者: Memorial 時間: 2025-3-27 04:20 作者: chalice 時間: 2025-3-27 07:17
978-981-15-2726-5The Editor(s) (if applicable) and The Author(s) 2020作者: Hypomania 時間: 2025-3-27 12:45
https://doi.org/10.1007/978-981-15-2724-1Pharmaceutical policy; counterfeit medicines; medicines promotion; generic medicines; pharmacy health se作者: 利用 時間: 2025-3-27 15:25
Zaheer-Ud-Din BabarThe only text available today which provides an up to date account of international pharmaceutical policy research.Analyses the most relevant areas that may impact on the quality use of medicines and 作者: Glucocorticoids 時間: 2025-3-27 18:16
Medicines Safety in the Globalized Context, pharmacovigilance system is important in the current global scenario and how it improves patient health. The chapter describes a summary of best practices related to medicines safety. There are examples of pharmacovigilance from America,?Canada, New Zealand and other?developed and developing countr作者: 放肆的你 時間: 2025-3-28 01:51
,Managing the Pharmaceutical Supply Chain—To Sustainability and Beyond,harmaceutical supply chain, sustainability can mean business survival; addressing resource depletion; manufacturing in a conscientious and responsible manner; contributing to our economy and doing no harm to our society and communities. To act sustainably is a challenge in a supply chain which conti作者: comely 時間: 2025-3-28 05:30 作者: panorama 時間: 2025-3-28 07:38
Global Access to Cancer Medicines,ries. When comparing it by global economic levels, the Global North shows relatively low mortality rate due to screening, early detection and development and availability of treatment therapy. Recently, anticancer drugs are becoming more expensive. However, it is questionable whether the high cost i作者: eczema 時間: 2025-3-28 11:18 作者: 宣傳 時間: 2025-3-28 18:04 作者: 免除責任 時間: 2025-3-28 19:12
Promoting Access to Cancer Medicines in Mexico: , Key Policy Components,ure (FPGC). This chapter describes how SP addressed the components of the WHO Access to Medicines Framework on access to cancer medicines..SP’s reimburserment guidelines cover medicines for basic cancer care and define reference prices, which are similar to international reference prices. Eight perc作者: 演講 時間: 2025-3-29 01:09
Access to Medicines: Case Studies from Russia and Kyrgyzstan,iovascular medicines were 6 times higher than in Russia, whilst their affordability was 9 times lower than in Russia for lowest-priced generics and 11 times lower for originator brands. Antihypertensive pharmacotherapy was affordable in Russia, but not in Kyrgyzstan (2015). We monitored patient and 作者: 協(xié)定 時間: 2025-3-29 03:19
Access and Use of Medicines in Ukraine,rsal health coverage was guaranteed by the Constitution with free access to healthcare services for all citizens. Due to the range of reasons, access to healthcare services and to medicines was highly restricted in the country. During the past decade the public health spending was consistently low i作者: 刺耳 時間: 2025-3-29 08:51
Public Participation in Access to Medicines,icing, financing, reliable systems and rational selection, aspects detailed in other chapters of this book. In all of these areas however, the role of public participation is essential, which we detail in the current chapter, by providing the general context, discussing their role in research, in re作者: FRAX-tool 時間: 2025-3-29 11:55 作者: 態(tài)學 時間: 2025-3-29 16:25
Access to Vaccines and Immunization Programme,cine is one of the foci among health policy makers around the globe. To improve the access to vaccine and immunization programme, several health policies have been implemented including WHO Expanded Programme on Immunization (EPI), the establishment of Global Alliance for Vaccines and Immunisation (作者: 奇思怪想 時間: 2025-3-29 22:22
Global Antibiotics Use and Resistance,n drivers of antimicrobial resistance. It has been demonstrated that there might be a threshold of antibiotic use beyond which resistance would be triggered. A threshold is an estimate of the maximum use of any antibiotic in a population that can be used over a specific period without having resista作者: 節(jié)省 時間: 2025-3-30 02:50
Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to that, more than a list of front-end articles for a fledgling journal (.) and its contemporary, the .. As readers we often flick through a range of journals and read interesting editorials and viewpoints. It is not often we will sit down and read the editorials from one journal source and ponder the 作者: 罵人有污點 時間: 2025-3-30 04:39
https://doi.org/10.1007/978-4-431-67899-1 pharmacovigilance system is important in the current global scenario and how it improves patient health. The chapter describes a summary of best practices related to medicines safety. There are examples of pharmacovigilance from America,?Canada, New Zealand and other?developed and developing countr作者: conscribe 時間: 2025-3-30 09:02
